Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Alkermes - 34 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits and dividends. The latest closing stock price for Alkermes as of January 30, 2025 is 31.91.
  • The all-time high Alkermes stock closing price was 98.05 on March 01, 2000.
  • The Alkermes 52-week high stock price is 32.88, which is 3% above the current share price.
  • The Alkermes 52-week low stock price is 22.90, which is 28.2% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 27.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 29.7847 28.7500 31.9100 28.0800 31.9100 10.95%
2024 27.0795 28.6200 32.5600 23.0100 28.7600 3.68%
2023 28.1991 25.8700 33.6300 23.3700 27.7400 6.16%
2022 25.8508 24.1500 31.8700 21.9400 26.1300 12.34%
2021 24.3680 19.7400 32.1300 18.2100 23.2600 16.59%
2020 17.6377 19.7600 22.1000 13.0600 19.9500 -2.21%
2019 25.4200 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0874 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.106B $1.663B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $151.412B 14.66
Bristol Myers Squibb (BMY) United States $119.764B 50.47
Gilead Sciences (GILD) United States $119.131B 21.58
Vertex Pharmaceuticals (VRTX) United States $113.704B 0.00
CSL (CSLLY) Australia $83.506B 0.00
Regeneron Pharmaceuticals (REGN) United States $75.524B 17.19
GSK (GSK) United Kingdom $72.664B 8.41
Argenex SE (ARGX) Netherlands $39.526B 0.00
Alnylam Pharmaceuticals (ALNY) United States $35.339B 0.00
BioNTech SE (BNTX) Germany $29.047B 0.00
BeiGene (ONC) Cayman Islands $22.154B 0.00
Biogen (BIIB) United States $21.043B 9.04
Illumina (ILMN) United States $20.891B 76.14
Moderna (MRNA) United States $15.670B 0.00
Incyte (INCY) United States $14.202B 0.00
Insmed (INSM) United States $13.954B 0.00
Intra-Cellular Therapies (ITCI) United States $13.466B 0.00
Genmab (GMAB) Denmark $13.136B 19.27
Genmab (GNMSF) Denmark $12.927B 15.50
BioMarin Pharmaceutical (BMRN) United States $12.094B 28.08
Bio-Techne Corp (TECH) United States $11.413B 44.07
Vaxcyte (PCVX) United States $11.052B 0.00
Sarepta Therapeutics (SRPT) United States $11.028B 99.53
Exact Sciences (EXAS) United States $10.159B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Bio-Rad Laboratories (BIO.B) United States $10.013B 34.03
QIAGEN (QGEN) Netherlands $9.711B 19.98
Repligen (RGEN) United States $9.491B 123.65
Exelixis (EXEL) United States $9.413B 21.40
Roivant Sciences (ROIV) United Kingdom $8.102B 0.00
Ascendis Pharma (ASND) Denmark $7.741B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.513B 7.35
Blueprint Medicines (BPMC) United States $7.262B 0.00
Zealand Pharma (ZLDPF) Denmark $7.120B 0.00
Halozyme Therapeutics (HALO) United States $7.103B 16.04
Revolution Medicines (RVMD) United States $6.884B 0.00
Legend Biotech (LEGN) United States $6.593B 0.00
Telix Pharmaceuticals (TLX) Australia $6.223B 0.00
Nuvalent (NUVL) United States $6.076B 0.00
Guardant Health (GH) United States $5.887B 0.00
Cytokinetics (CYTK) United States $5.741B 0.00
TG Therapeutics (TGTX) United States $5.195B 0.00
Axsome Therapeutics (AXSM) United States $5.095B 0.00
Krystal Biotech (KRYS) United States $4.495B 74.43
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.383B 0.00
Scholar Rock Holding (SRRK) United States $3.984B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.922B 0.00
ADMA Biologics Inc (ADMA) United States $3.872B 40.95
Biohaven (BHVN) United States $3.815B 0.00
Avidity Biosciences (RNA) United States $3.808B 0.00
Alvotech (ALVO) Luxembourg $3.790B 0.00
Akero Therapeutics (AKRO) United States $3.769B 0.00
Viking Therapeutics (VKTX) United States $3.725B 0.00
Immunovant (IMVT) United States $3.701B 0.00
Apellis Pharmaceuticals (APLS) United States $3.666B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.517B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.515B 0.00
Arcellx (ACLX) United States $3.492B 0.00
PTC Therapeutics (PTCT) United States $3.488B 0.00
Denali Therapeutics (DNLI) United States $3.369B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.064B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.057B 23.55
Zai Lab (ZLAB) China $2.981B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.943B 0.00
Twist Bioscience (TWST) United States $2.939B 0.00
Vericel (VCEL) United States $2.911B 983.00
Amicus Therapeutics (FOLD) United States $2.866B 0.00
Merus (MRUS) Netherlands $2.852B 0.00
NovoCure (NVCR) Jersey $2.761B 0.00
SpringWorks Therapeutics (SWTX) United States $2.717B 0.00
Edgewise Therapeutics (EWTX) United States $2.691B 0.00
Kymera Therapeutics (KYMR) United States $2.552B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.482B 0.00
Vera Therapeutics (VERA) United States $2.402B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.378B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.333B 0.00
CG Oncology (CGON) United States $2.303B 0.00
Mesoblast (MESO) Australia $2.281B 0.00
Protagonist Therapeutics (PTGX) United States $2.277B 14.36
Ligand Pharmaceuticals (LGND) United States $2.247B 56.09
Certara (CERT) United States $2.236B 63.14
Janux Therapeutics (JANX) United States $2.231B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.214B 18.40
ImmunityBio (IBRX) United States $2.202B 0.00
Beam Therapeutics (BEAM) United States $2.145B 0.00
Bavarian Nordic (BVNRY) Denmark $2.119B 12.99
IDEAYA Biosciences (IDYA) United States $2.069B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.029B 0.00
Agios Pharmaceuticals (AGIO) United States $1.924B 0.00
NeoGenomics (NEO) United States $1.870B 0.00
Iovance Biotherapeutics (IOVA) United States $1.850B 0.00
WAVE Life Sciences (WVE) Singapore $1.817B 0.00
Apogee Therapeutics (APGE) United States $1.815B 0.00
Belite Bio (BLTE) United States $1.772B 0.00
Structure Therapeutics (GPCR) United States $1.761B 0.00
Geron (GERN) United States $1.747B 0.00
Dynavax Technologies (DVAX) United States $1.706B 99.85
Celldex Therapeutics (CLDX) United States $1.692B 0.00
MannKind (MNKD) United States $1.685B 43.64
Disc Medicine (IRON) United States $1.663B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.606B 0.00
Travere Therapeutics (TVTX) United States $1.596B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.583B 0.00
Viridian Therapeutics (VRDN) United States $1.539B 0.00
Galapagos (GLPG) Belgium $1.527B 0.00
Vir Biotechnology (VIR) United States $1.501B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.492B 0.00
Nurix Therapeutics (NRIX) United States $1.491B 0.00
Fortrea Holdings (FTRE) United States $1.480B 47.14
Novavax (NVAX) United States $1.411B 0.00
Praxis Precision Medicines (PRAX) United States $1.380B 0.00
MiMedx (MDXG) United States $1.330B 34.81
Day One Biopharmaceuticals (DAWN) United States $1.312B 0.00
ANI Pharmaceuticals (ANIP) United States $1.248B 17.01
Syndax Pharmaceuticals (SNDX) United States $1.215B 0.00
Liquidia Technologies (LQDA) United States $1.207B 0.00
Arvinas (ARVN) United States $1.206B 0.00
Pacira BioSciences (PCRX) United States $1.202B 11.32
Arcus Biosciences (RCUS) United States $1.191B 0.00
Myriad Genetics (MYGN) United States $1.142B 0.00
Adaptive Biotechnologies (ADPT) United States $1.138B 0.00
Spyre Therapeutics (SYRE) United States $1.126B 0.00
Gyre Therapeutics (GYRE) United States $1.074B 0.00
Intellia Therapeutics (NTLA) United States $1.031B 0.00
Cogent Biosciences (COGT) United States $1.027B 0.00
Zymeworks (ZYME) United States $1.006B 0.00
ArriVent BioPharma (AVBP) United States $0.978B 0.00
Replimune (REPL) United States $0.963B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.949B 0.00
AbCellera Biologics (ABCL) Canada $0.945B 0.00
89BIO (ETNB) United States $0.926B 0.00
Pharvaris (PHVS) Netherlands $0.922B 0.00
Oculis Holding AG (OCS) Switzerland $0.897B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.896B 0.00
GRAIL (GRAL) United States $0.896B 0.00
CureVac (CVAC) Germany $0.866B 7.04
Prothena (PRTA) Ireland $0.851B 0.00
Anavex Life Sciences (AVXL) United States $0.823B 0.00
Nuvation Bio (NUVB) United States $0.814B 0.00
Avid Bioservices (CDMO) United States $0.796B 0.00
Oric Pharmaceuticals (ORIC) United States $0.787B 0.00
Castle Biosciences (CSTL) United States $0.770B 137.45
UniQure (QURE) Netherlands $0.743B 0.00
Tyra Biosciences (TYRA) United States $0.741B 0.00
Cytek Biosciences (CTKB) United States $0.733B 0.00
Sana Biotechnology (SANA) United States $0.726B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.704B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
LENZ Therapeutics (LENZ) United States $0.692B 0.00
Opthea (OPT) Australia $0.692B 0.00
Septerna (SEPN) United States $0.690B 0.00
CorMedix Inc (CRMD) United States $0.685B 0.00
Cullinan Therapeutics (CGEM) United States $0.655B 0.00
Pliant Therapeutics (PLRX) United States $0.654B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.640B 0.00
Bicara Therapeutics (BCAX) United States $0.640B 0.00
Immatics (IMTX) Germany $0.636B 0.00
Dianthus Therapeutics (DNTH) United States $0.617B 0.00
CARGO Therapeutics (CRGX) United States $0.607B 0.00
Pharming Group (PHAR) Netherlands $0.600B 0.00
Kura Oncology (KURA) United States $0.598B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.589B 0.00
Emergent Biosolutions (EBS) United States $0.585B 0.00
Immunome (IMNM) United States $0.584B 0.00
Humacyte (HUMA) United States $0.574B 0.00
Rapport Therapeutics (RAPP) United States $0.572B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.569B 0.00
Stoke Therapeutics (STOK) United States $0.557B 0.00
Upstream Bio (UPB) United States $0.549B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.537B 0.00
AnaptysBio (ANAB) United States $0.530B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.528B 0.00
Erasca (ERAS) United States $0.520B 0.00
Mineralys Therapeutics (MLYS) United States $0.516B 0.00
Entrada Therapeutics (TRDA) United States $0.496B 8.34
GH Research (GHRS) Ireland $0.491B 0.00
MaxCyte (MXCT) United States $0.491B 0.00
Alpha Teknova (TKNO) United States $0.489B 0.00
Cartesian Therapeutics (RNAC) United States $0.489B 0.00
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
Keros Therapeutics (KROS) United States $0.461B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.456B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.455B 0.00
ChromaDex (CDXC) United States $0.451B 590.00
Sage Therapeutics (SAGE) United States $0.448B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.448B 0.00
PureTech Health (PRTC) United States $0.446B 0.00
Eton Pharmaceuticals (ETON) United States $0.445B 0.00
Annexon (ANNX) United States $0.439B 0.00
Absci (ABSI) United States $0.430B 0.00
Compass Therapeutics (CMPX) United States $0.428B 0.00
Celcuity (CELC) United States $0.426B 0.00
Astria Therapeutics (ATXS) United States $0.421B 0.00
Aura Biosciences (AURA) United States $0.396B 0.00
Kamada (KMDA) Israel $0.387B 24.07
Allogene Therapeutics (ALLO) United States $0.386B 0.00
Precigen (PGEN) United States $0.381B 0.00
Revance Therapeutics (RVNC) United States $0.380B 0.00
Tectonic Therapeutic (TECX) United States $0.379B 0.00
Northwest Biotherapeutics (NWBO) United States $0.379B 0.00
REGENXBIO (RGNX) United States $0.373B 0.00
Abivax SA (ABVX) France $0.372B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.368B 0.00
Chimerix (CMRX) United States $0.366B 0.00
Codexis (CDXS) United States $0.364B 0.00
Prime Medicine (PRME) United States $0.361B 0.00
Olema Pharmaceuticals (OLMA) United States $0.356B 0.00
Kodiak Sciences (KOD) United States $0.355B 0.00
Terns Pharmaceuticals (TERN) United States $0.355B 0.00
MBX Biosciences (MBX) United States $0.343B 0.00
Tango Therapeutics (TNGX) United States $0.334B 0.00
EnGene Holdings (ENGN) Canada $0.327B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.326B 0.00
XOMA Royalty (XOMA) United States $0.312B 0.00
Neumora Therapeutics (NMRA) United States $0.312B 0.00
Alumis (ALMS) United States $0.308B 0.00
ATyr Pharma (ATYR) United States $0.305B 0.00
Zenas BioPharma (ZBIO) United States $0.305B 0.00
Voyager Therapeutics (VYGR) United States $0.302B 7.77
Prima BioMed (IMMP) Australia $0.298B 0.00
Trevi Therapeutics (TRVI) United States $0.297B 0.00
Rezolute (RZLT) United States $0.293B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.283B 0.00
Design Therapeutics (DSGN) United States $0.280B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.275B 0.00
ITeos Therapeutics (ITOS) United States $0.274B 0.00
Verastem (VSTM) United States $0.268B 0.00
Contineum Therapeutics (CTNM) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.264B 0.00
AC Immune (ACIU) Switzerland $0.261B 0.00
Urogen Pharma (URGN) United States $0.258B 0.00
Semper Paratus Acquisition (TVGN) United States $0.254B 0.00
C4 Therapeutics (CCCC) United States $0.253B 0.00
Atea Pharmaceuticals (AVIR) United States $0.253B 0.00
Benitec Biopharma (BNTC) United States $0.252B 0.00
DiaMedica Therapeutics (DMAC) United States $0.252B 0.00
BioStem Technologies (BSEM) $0.249B 21.99
Anika Therapeutics (ANIK) United States $0.248B 0.00
Abeona Therapeutics (ABEO) United States $0.237B 0.00
Monopar Therapeutics (MNPR) United States $0.237B 0.00
Sangamo Therapeutics (SGMO) United States $0.236B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
Amarin (AMRN) Ireland $0.232B 0.00
Neurogene (NGNE) United States $0.230B 0.00
Lifecore Biomedical (LFCR) United States $0.224B 0.00
Foghorn Therapeutics (FHTX) United States $0.221B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
Fulcrum Therapeutics (FULC) United States $0.220B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
Ocugen (OCGN) United States $0.216B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.214B 0.00
TuHURA Biosciences (HURA) United States $0.214B 0.00
Molecular Partners AG (MOLN) Switzerland $0.211B 0.00
Gossamer Bio (GOSS) United States $0.208B 0.00
Compugen (CGEN) Israel $0.208B 116.50
Orchestra BioMed Holdings (OBIO) United States $0.206B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.203B 0.00
INmune Bio (INMB) United States $0.201B 0.00
ACELYRIN, INC (SLRN) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
Adocia (ADOCY) France $0.185B 0.00
Inhibrx Biosciences (INBX) United States $0.178B 0.00
BioAge Labs (BIOA) United States $0.178B 0.00
Adherex Technologies (FENC) United States $0.178B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Greenwich LifeSciences (GLSI) United States $0.174B 0.00
Instil Bio (TIL) United States $0.172B 0.00
Actuate Therapeutics (ACTU) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.163B 0.00
Alector (ALEC) United States $0.161B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.160B 0.00
Nkarta (NKTX) United States $0.158B 0.00
Sutro Biopharma (STRO) United States $0.155B 0.00
Biomea Fusion (BMEA) United States $0.153B 0.00
Puma Biotechnology (PBYI) United States $0.151B 6.40
Palvella Therapeutics (PVLA) United States $0.149B 0.00
Fate Therapeutics (FATE) United States $0.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.149B 0.00
Akoya Biosciences (AKYA) United States $0.149B 0.00
Innate Pharma S.A (IPHA) France $0.148B 0.00
Coherus BioSciences (CHRS) United States $0.141B 0.00
Genelux (GNLX) United States $0.141B 0.00
Kyverna Therapeutics (KYTX) United States $0.140B 0.00
Checkpoint Therapeutics (CKPT) United States $0.139B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 0.00
Seres Therapeutics (MCRB) United States $0.137B 0.00
Seer (SEER) United States $0.137B 0.00
Ventyx Biosciences (VTYX) United States $0.137B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.135B 0.00
TScan Therapeutics (TCRX) United States $0.133B 0.00
Solid Biosciences (SLDB) United States $0.133B 0.00
Bright Minds Biosciences (DRUG) United States $0.132B 0.00
InflaRx (IFRX) Germany $0.132B 0.00
Artiva Biotherapeutics (ARTV) United States $0.131B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
X4 Pharmaceuticals (XFOR) United States $0.125B 0.00
Sagimet Biosciences (SGMT) United States $0.124B 0.00
Nuvectis Pharma (NVCT) United States $0.123B 0.00
Caribou Biosciences (CRBU) United States $0.121B 0.00
Renovaro (RENB) United States $0.121B 0.00
Inventiva S.A (IVA) France $0.121B 0.00
Cabaletta Bio (CABA) United States $0.116B 0.00
Alto Neuroscience (ANRO) United States $0.114B 0.00
Zura Bio (ZURA) United States $0.113B 0.00
Editas Medicine (EDIT) United States $0.111B 0.00
XBiotech (XBIT) United States $0.110B 0.00
Scilex Holding (SCLX) United States $0.109B 0.00
TELA Bio (TELA) United States $0.109B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.107B 0.00
Skye Bioscience (SKYE) United States $0.104B 0.00
Elicio Therapeutics (ELTX) United States $0.104B 0.00
Elutia (ELUT) United States $0.103B 0.00
Alpha Cognition (ACOG) Canada $0.101B 0.00
CAMP4 Therapeutics (CAMP) United States $0.100B 0.00
Invizyne Technologies (IZTC) United States $0.099B 0.00
MediciNova (MNOV) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
HilleVax (HLVX) United States $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Vor Biopharma (VOR) $0.095B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.094B 0.00
Inozyme Pharma (INZY) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (ME) United States $0.090B 0.00
Vigil Neuroscience (VIGL) United States $0.090B 0.00
Immunic (IMUX) United States $0.089B 0.00
IGM Biosciences (IGMS) United States $0.087B 0.00
DBV Technologies S.A (DBVT) France $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.087B 0.00
Aligos Therapeutics (ALGS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Citius Oncology (CTOR) United States $0.086B 0.00
I-Mab (IMAB) China $0.086B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Cue Biopharma (CUE) United States $0.085B 0.00
Agenus (AGEN) United States $0.085B 0.00
Cellectis S.A (CLLS) France $0.084B 0.00
Tenaya Therapeutics (TNYA) United States $0.083B 0.00
Adagene (ADAG) China $0.082B 0.00
BioHarvest Sciences (BHST) Canada $0.081B 0.00
Rani Therapeutics Holdings (RANI) United States $0.080B 0.00
VistaGen Therapeutics (VTGN) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.077B 0.00
Adlai Nortye (ANL) Cayman Islands $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Adicet Bio (ACET) United States $0.074B 0.00
Bluebird Bio (BLUE) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Theratechnologies (THTX) Canada $0.073B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.073B 0.00
Mersana Therapeutics (MRSN) United States $0.073B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Quince Therapeutics (QNCX) United States $0.072B 0.00
Aadi Bioscience (AADI) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
Annovis Bio (ANVS) United States $0.067B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.067B 0.00
BGM Group (BGM) China $0.066B 0.00
Earth Science Tech (ETST) United States $0.065B 0.00
CytomX Therapeutics (CTMX) United States $0.064B 4.82
Oncobiologics (OTLK) United States $0.064B 0.00
Applied Therapeutics (APLT) United States $0.063B 0.00
Shattuck Labs (STTK) United States $0.063B 0.00
IO Biotech (IOBT) Denmark $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
PepGen (PEPG) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Immuneering (IMRX) United States $0.059B 0.00
Oncolytics Biotech (ONCY) Canada $0.058B 0.00
Abpro Holdings (ABP) United States $0.058B 0.00
Generation Bio (GBIO) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.057B 0.00
FibroBiologics (FBLG) United States $0.055B 0.00
Boundless Bio (BOLD) United States $0.055B 0.00
Rein Therapeutics (RNTX) United States $0.054B 0.00
KALA BIO (KALA) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Celularity (CELU) United States $0.051B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.049B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
Repare Therapeutics (RPTX) Canada $0.049B 0.00
Fortress Biotech (FBIO) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Spero Therapeutics (SPRO) United States $0.047B 12.28
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.046B 0.00
Invivyd (IVVD) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Rapt Therapeutics (RAPT) United States $0.041B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.040B 0.00
Q32 Bio (QTTB) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.038B 0.00
UNITY Biotechnology (UBX) United States $0.038B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
Elevation Oncology (ELEV) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Rallybio (RLYB) United States $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Passage Bio (PASG) United States $0.036B 0.00
CalciMedica (CALC) United States $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.033B 0.00
Cadrenal Therapeutics (CVKD) United States $0.033B 0.00
Enzo Biochem (ENZ) United States $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
Xilio Therapeutics (XLO) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.031B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Pulmatrix (PULM) United States $0.029B 0.00
Beyond Air (XAIR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
Exicure (XCUR) United States $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Omega Therapeutics (OMGA) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Equillium (EQ) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Allakos (ALLK) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.022B 0.00
Leap Therapeutics (LPTX) United States $0.022B 0.00
NKGen Biotech (NKGN) United States $0.022B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
IN8bio (INAB) United States $0.019B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
OnKure Therapeutics (OKUR) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.016B 0.00
Affimed (AFMD) Germany $0.016B 0.00
Dogwood Therapeutics (DWTX) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
BioAffinity Technologies (BIAF) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
HCW Biologics (HCWB) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Apollomics (APLM) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Hoth Therapeutics (HOTH) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.008B 0.00
Ocean Biomedical (OCEA) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Novogen (KZIA) Australia $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Allarity Therapeutics (ALLR) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Eyenovia (EYEN) United States $0.004B 0.00
Evaxion Biotech (EVAX) Denmark $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Vincerx Pharma (VINC) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00